Companies/2cureX AB
Follow

2cureX AB

Nasdaq First North GM Stockholm (Sweden)

2cureX is a biotech company. The Company is engaged in improving treatment efficiency, mainly for cancer patients. It is involved in developing a product, namely IndiTreat, which is a technology for the treatment of colorectal, ovarian, and pancreatic cancers.
Go to market

Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Media
Showing 3 of 8
View all
www.2curex.com
Current instruments
Type
Ticker
ISIN
SHARE
2CUREX
SE0010468124
Nasdaq First North GM Stockholm Sweden (SE)
Top
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
2CUREX
SE0010468124
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in 2cureX AB with ticker 2CUREX
Status
Active
Currency
SEK
First trading date
24 Oct 2017
Rights issue
Sign in to buy
Directed issue
Sign in to buy
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
2CUREX
SE0010468124
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in 2cureX AB with ticker 2CUREX
Status
Active
Currency
SEK
First trading date
24 Oct 2017
Rights issue
Sign in to buy
Directed issue
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
2CUREX TO1
SE0014684494
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in 2cureX AB with ticker 2CUREX TO1
Status
Archived
Currency
SEK
Trading period
06 Aug 2020 - 05 May 2021
Terms
For every ten (10) owned shares in the Company on the record date (17.07.2020), one (1) warrant of series TO1 will be received. Each warrant of series TO1 entitles the holder to subscribe for one (1) new share for the price whihch corresponds to 70 percent of the average volume-weighted share price according to Nasdaq First North Growth Market’s official price statistics during the period from April 9, 2021 - April 22, 2021.
Update (13.07.2020): Record date for allotment of warrants of series TO1 is set to - July 17, 2020.
Update (04.08.2020): First day for trading in TO1 series warrants.
Update (23.04.2021): The exercise price for the warrants of series TO1 in 2cureX AB has been determined to SEK 13.22 and the subscription period starts April 26, 2021.
Update (05.05.2021): The last day of trading with the warrants of series TO1 is May 5, 2021.
Exercise
Sign in to buy
People
Fernando Andreu
CEO
Povl-Andre Bendz
Chairman of the board
Ole Thastrup
Board member
Jørgen Drejer
Board member
Juan Farré
Board member
Simon Hesse Hoffmann
Board member
Timm Jessen
Board member
Ulrich Spengler
Board member
Michael Schaefer
Board member
Company Details
Sector
HEALTH CARE
Website
Address
Fruebjergvej 3
Zip code
2100
City/district
Copenhagen
Country
Denmark (DK)
Phones
Email
[email protected]
Registration number
559128-0077
LEI code
549300SFOL75WIYF2O80
First trade date
24 Oct 2017
Registration date
05 Oct 2017
Short name
2cureX

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More